Hypothesis
Patients with gynecologic cancers treated at high-volume or teaching hospitals would survive longer, supporting regionalisation of care.
What failed
Among 48,981 Florida patients treated 1990–2000, univariate analysis suggested better short-term survival at high-volume centres, but multivariate analysis showed no significant survival benefit for teaching or high-volume facilities for any of the five gynecologic cancers.
Broken assumption
Higher hospital volume or teaching status improves survival in gynecologic cancer.
Why
Patients at high-volume centres were significantly younger; once age, race, stage and treatment were accounted for, the apparent advantage disappeared.
From the published paper: Brookfield et al. PLoS ONE, 2009. ↗CC BY